Small Molecule Development & Manufacturing CDMOs in Asia-Pacific
29 published
29 published CDMOs match Small Molecule Development & Manufacturing in Asia-Pacific.
Locations in this set include India, United States, China, France, Switzerland, and United Kingdom.
Capabilities that show up most often in this set: Small Molecule, Peptide, Antibody-Drug Conjugate (ADC), Biologics (Other), and Biologics (Monoclonal Antibodies).
Matching companies
PortonPorton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
Roquette Pharma SolutionsRoquette is a leading global provider of plant-based ingredients, excipients, and solutions for the pharmaceutical and healthcare industries.
SK pharmtecoSK pharmteco is a CDMO offering comprehensive drug development and manufacturing services.
Sai Life SciencesIntegrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.
Sparge Chem Pvt. Ltd.Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Winkem Labs Pvt. Ltd.Contract development and manufacturing organization (CDMO) offering complex chemical synthesis, process development, API manufacturing, and supply services for pharmaceutical clients globally.
Yongtai TechnologyYongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.- 重庆兴泰濠制药有限公司 (Sintaho)China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.
Markdown mirror: /services/small-molecule-development-manufacturing/apac.md